Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00108108
Status:
TERMINATED
Last Update Posted:
2012-10-01
First Post:
2005-04-14
Brief Title:
Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia CLL That is Relapsed or Non-responsive to Prior Fludaribine Therapy
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-04
Start Date Type:
None
Primary Completion Date:
2008-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-06
Completion Date Type:
ACTUAL
First Submit Date:
2005-04-14
First Submit QC Date:
April 14 2005
Study First Post Date:
2005-04-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-09-28
Last Update Post Date:
2012-10-01
Last Update Post Date Type:
ESTIMATED